Table 3.

The pooled prevalence of suicide attempt in transgender population based on type of TS, and continents

Outcomes	Number of studies	Pooled prevalence %	95 CI		Heterogeneity assessment
			Lower %	Upper %	I square %	Z	P value
Overall prevalence	82	26	22	31	95.51	18.01	< 0.0001
Type of prevalence
Point prevalence	2	16	13	19	88.10	17.18	< 0.0001
Period prevalence	10	11	5	19	99.26	5.66	< 0.0001
Life time prevalence	70	29	25	34	99.11	22.54	< 0.0001
Type of TS
Female to male
Overall/life time prevalence	11	22	13	31	96.79	7.98	< 0.0001
Male to female
Overall	17	25	21	30	91.14	18.83	< 0.0001
Period prevalence	1	13	10	17	–	13.54	< 0.0001
Life time prevalence	16	26	22	30	89.56	19.74	< 0.0001
Both
Overall	54	28	22	34	98.67	14.53	< 0.0001
Period prevalence	9	11	5	20	89.31	5.29	< 0.0001
Point prevalence	2	16	13	19	88.88	17.18	< 0.0001
Life time prevalence	43	33	27	38	89.38	18.81	< 0.0001
Continents
Europe
Overall/life time prevalence	10	33	29	36	74.95	30.53	< 0.0001
Asia
Overall/life time prevalence	12	23	18	28	94.51	14.17	< 0.0001
America
Overall	56	25	19	32	99.64	13.24	< 0.0001
Point prevalence	1	14	8	22	87.33	7.56	< 0.0001
Period prevalence	10	11	5	19	89.26	5.66	< 0.0001
Life time prevalence	45	29	24	35	89.36	16.23	< 0.0001
Australia
Overall	4	38	26	52	97.87	9.42	< 0.0001
Point prevalence	1	17	13	21	–	15.80	< 0.0001
Life time prevalence	3	46	40	52	88.79	24.57	< 0.0001
Continents
Europe
MTF	4	32	25	39	54.76	14.98	0.080
FTM	4	34	23	45	88.87	10.00	< 0.0001
Both	2	34	33	35	88.00	94.50	< 0.0001
Asia
MTF	5	26	19	34	91.97	11.52	< 0.0001
FTM	2	11	9	13	88.79	22.44	< 0.0001
Both	5	26	15	38	94.41	6.94	< 0.0001
America
MTF	8	21	15	29	93.46	10.44	< 0.0001
FTM	5	18	6	35	96.30	3.88	< 0.0001
Both	43	27	20	35	98.72	11.84	< 0.0001
Australia
Both	4	38	26	52	97.87	9.42	< 0.0001

MTF: male to female; FTM: female to male; TS: transgender; CI: confidence interval